Related Experiment Video
Updated: Mar 14, 2026

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
PCOS remains a diagnosis of exclusion: a concise review of key endocrinopathies to exclude
Eleni Magdalini Kyritsi1, George K Dimitriadis1,2,3, Ioannis Kyrou1,2,4
1Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism, University Hospitals of Coventry and Warwickshire NHS Trust, Coventry, United Kingdom.
Abstract:
Polycystic ovarian syndrome (PCOS) is a heterogenous disorder associated with clinical, endocrine and ultrasonographic features that can also be encountered in a number of other diseases. It has traditionally been suggested that prolactin excess, enzymatic steroidogenic abnormalities and thyroid disorders need to be excluded before a diagnosis of PCOS is made. However, there is paucity of data regarding the prevalence of PCOS phenotype in some of these disorders, whereas other endocrine diseases that exhibit PCOS-like features may elude diagnosis and proper management if not considered. This article reviews the data of currently included entities that exhibit a PCOS phenotype and those that potentially need to be looked for, and attempts to identify specific features that distinguish them from idiopathic PCOS.
Related Concept Videos
Oogenesis
Disorders of the Female Reproductive System
Infertility in Females
Endometriosis, a condition characterized by abnormal growth of...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
The Endocrine System
Chronic Pancreatitis II: Collaborative Care
Assessment:

